- Home
- DNTH vs AMSF Comparison
DNTH vs AMSF Comparison
Compare DNTH & AMSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- AMSF
- Stock Information
- Founded
- DNTH 2015
- AMSF 1985
- Country
- DNTH United States
- AMSF United States
- Employees
- DNTH N/A
- AMSF N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- AMSF Accident &Health Insurance
- Sector
- DNTH Health Care
- AMSF Finance
- Exchange
- DNTH Nasdaq
- AMSF Nasdaq
- Market Cap
- DNTH 823.1M
- AMSF 968.5M
- IPO Year
- DNTH N/A
- AMSF 2005
- Fundamental
- Price
- DNTH $20.27
- AMSF $58.07
- Analyst Decision
- DNTH Strong Buy
- AMSF Buy
- Analyst Count
- DNTH 8
- AMSF 2
- Target Price
- DNTH $46.43
- AMSF $59.50
- AVG Volume (30 Days)
- DNTH 291.2K
- AMSF 101.7K
- Earning Date
- DNTH 11-07-2024
- AMSF 10-23-2024
- Dividend Yield
- DNTH N/A
- AMSF 7.64%
- EPS Growth
- DNTH N/A
- AMSF N/A
- EPS
- DNTH N/A
- AMSF 3.21
- Revenue
- DNTH $5,366,000.00
- AMSF $315,182,000.00
- Revenue This Year
- DNTH $44.94
- AMSF N/A
- Revenue Next Year
- DNTH N/A
- AMSF $1.81
- P/E Ratio
- DNTH N/A
- AMSF $18.09
- Revenue Growth
- DNTH 51.41
- AMSF 2.81
- 52 Week Low
- DNTH $6.58
- AMSF $41.97
- 52 Week High
- DNTH $33.77
- AMSF $60.24
- Technical
- Relative Strength Index (RSI)
- DNTH 22.81
- AMSF 64.08
- Support Level
- DNTH $22.19
- AMSF $57.10
- Resistance Level
- DNTH $28.56
- AMSF $58.94
- Average True Range (ATR)
- DNTH 2.02
- AMSF 1.21
- MACD
- DNTH -0.88
- AMSF -0.22
- Stochastic Oscillator
- DNTH 3.38
- AMSF 68.27
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About AMSF AMERISAFE Inc.
AMERISAFE Inc is a specialty provider of workers' compensation insurance to employers engaged in hazardous industries, mainly construction, trucking, manufacturing, oil and gas, and agriculture. The company generates a majority of its revenue in the form of premiums.